|0.4833 0.013 (2.83%)||11-29 09:48|
|Targets||6-month :||0.59||1-year :||0.69|
|Resists||First :||0.5||Second :||0.59|
|Supports||First :||0.39||Second :||0.33|
|MAs||MA(5) :||0.48||MA(20) :||0.44|
|MA(100) :||0.76||MA(250) :||1.15|
|MACD||MACD :||-0.1||Signal :||-0.1|
|%K %D||K(14,3) :||78.3||D(3) :||86.4|
|52-week||High :||2.2||Low :||0.33|
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ AKLI ] has closed below upper band by 43.0%. Bollinger Bands are 54.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 9 bars. This is a sign that the market may be about to initiate a new trend.
|If tomorrow:||Open lower||Open higher|
|High:||0.5 - 0.5||0.5 - 0.51|
|Low:||0.46 - 0.47||0.47 - 0.47|
|Close:||0.47 - 0.47||0.47 - 0.47|
Akili, Inc., a digital medicine company, develops digital therapeutics for cognitive impairments. It provides EndeavorRx, a physician-prescribed video game-based treatment designed to directly target cognitive functioning. The company is based in Boston, Massachusetts.
Fri, 06 Oct 2023
Akili Announces Leadership Transition - Business Wire
|Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
|Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
|Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
|Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
|Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
|Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Health Information Services
|Shares Out||0 (M)|
|Shares Float||78 (M)|
|Held by Insiders||2.52e+007 (%)|
|Held by Institutions||18.4 (%)|
|Shares Short||92 (K)|
|Shares Short P.Month||0 (K)|
|EPS Est Next Qtrly||0|
|EPS Est This Year||0|
|EPS Est Next Year||0|
|Book Value (p.s.)||0|
|Profit Margin||0 %|
|Operating Margin||-2 %|
|Return on Assets (ttm)||624.7 %|
|Return on Equity (ttm)||-36.3 %|
|Qtrly Rev. Growth||1.04e+006 %|
|Gross Profit (p.s.)||507.44|
|Sales Per Share||-45.33|
|Qtrly Earnings Growth||-1.2 %|
|Operating Cash Flow||0 (M)|
|Levered Free Cash Flow||-70 (M)|
|Price to Book value||0|
|Price to Sales||-0.02|
|Price to Cash Flow||0.79|
|Dividend Pay Date||Invalid DateTime.|
|Ex-Dividend Date||Invalid DateTime.|